Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. cardiolite.com › healthcare-professionals › reimbursementReimbursement - Cardiolite

    Download Medicare Reimbursement Guide. If you have questions related to Cardiolite ® reimbursement, please call (800) 362-2668 (Option 3) or email reimbursement@lantheus.com. Lantheus cannot guarantee coverage or payment for products or procedures.

  2. www.cardiolite.com › pdfs › Cardiolite-US-PI-513121-0619CARDIOLITE

    CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.

  3. CARDIOLITE® is a myocardial perfusion agent indicated for: • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects)

  4. 25 Μαρ 2024 · Cardiolite package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

  5. Any kit for preparation of a radiopharmaceutical (e.g., Cardiolite for preparation of Tc 99m-Sestamibi, Myoview for preparation of Tc 99m-Tetrofosmin), is included in the reimbursement amount for the

  6. 26 Οκτ 2006 · The codes for Cardiolite and Myoview now have a specified limit: • Cardiolite: A9500 -- Technetium Tc-99m sestamibi, diagnostic, per study dose, up to 40 millicuries. • Myoview: A9502 -- Technetium Tc-99m tetrofosmin, diagnostic, per study dose, up to 40 millicuries.

  7. sestamibi (Cardiolite/DuPont Merck) and 99mTc teberoxime (Cardiotec/Squibb Diagnostics). These agents are alterna- tives to thallium-201 (2OlTI) for perfusion imaging, but the two new agents possess vastly different physical and pharmacokinetic properties from 2OtTI and from each other.

  1. Γίνεται επίσης αναζήτηση για